ロード中...
Novel biomarkers for the management of chronic hepatitis B
Hepatitis B virus (HBV) cannot be eliminated completely from infected hepatocytes because of the presence of intrahepatic covalently closed circular DNA (cccDNA). As chronic hepatitis B (CHB) can progress to cirrhosis and hepatocellular carcinoma (HCC), it is important to manage CHB to prevent HCC d...
保存先:
| 出版年: | Clin Mol Hepatol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Association for the Study of the Liver
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364351/ https://ncbi.nlm.nih.gov/pubmed/32536045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2020.0032 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|